Solid tumors in which IL‐1β has been shown to be up‐regulated include breast, colon, lung, and melanomas, and patients with IL‐1β producing tumors have generally bad prognoses (Lewis, Varghese, Xu, & Alexander, 2006). This evidence concerns the gene IL1B and melanoma.